Faculty | Professors

Clinical & Research Interests

Piero Verro has clinical expertise in the management of acute stroke through application of advanced methods such as thrombolysis and delivery of neuroprotectant medications to ischemic brain. His clinical interests also include outpatient evaluation and treatment of patients with cerebrovascular disease.  Dr. Verro organized and directs the acute stroke unit. He is collaborating with other researchers in multicenter clinical trials involving unique methods of reversing or minimizing the effects of acute stroke on functional outcome. He also is working to develop new methods to diagnose and assess the extent of irreversible brain ischemia to help facilitate acute treatment decisions. Verro holds a patent for his laser projection system for CT scanners, which performs parallax-free localization of anatomical landmarks.

Other Languages

Italian

Education

University of Wisconsin Medical School
Madison, Wisconsin
M.D. 1987

University of Connecticut
Storrs, Connecticut
B.S. 1971

Internships

University of Wisconsin Hospitals
Madison, Wisconsin
1987-88
Medicine

Residency

University of Wisconsin Hospitals
Madison, Wisconsin
1988-91
Neurology

Fellowships

Henry Ford Hospital
Detroit, Michigan
1993-94
Cerebrovascular Disease

University Hospital
London, Ontario
Canada
1992-93
Neuromuscular Disease

Medical College of Wisconsin
Milwaukee, Wisconsin
1991-92
Neurology

Board Certifications

American Board of Psychiatry and Neurology, 1996

Professional Memberships

American Academy of Neurology
American Stroke Association

Select Recent Publications

Brain air embolism due to Yag laser bronchoscopy.  American Academy of Neurology Resident Education Section.  Neurology 2010 in press

IV vs IA tPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study.  Sen S, Huang G, Akhavan O, Verro P, Solander S.  Neurocritical Care 2009

Prolonged dependence of ischemic penumbra on induced hypertension. Verro P, Chow M.  The Neurologist.  2009.

Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.  Verro P,  Gorelick P,  Nguyen, D  Stroke. 2008;39:1358-1363.

Genomic profiles of stroke in blood.  Sharp R, Huichun X, Lit L, Walker W, Pinter J, Apperson M, Verro P.  Stroke 2007;38[part2]:691-693.

Clinical application of CT angiography in acute ischemic stroke.  Verro P, Tanenbaum L, Borden N, Eshkar N, et al. Clinical Neurology and Neurosurgery.  2007; 109:138-145

Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.  Yang Tang, Huichun Xu \ XinLi Du, Lisa Lit, Wynn Walker, Aigang Lu, Ruiqiong Ran, Jeffrey P Greg, Melinda Reill, Art Pancioli, Jane C Khoury, Laura R Sauerbeck, JaniceA Carrozzella ,Judith Spilker, Joseph Clark, Kenneth R Wagner, Edward C Jauch,Dongwoo J Chang, Piero Verro, Joseph P Broderick, Frank R Sharp.  Journal of Cerebral Blood Row & Metabolism (2006),1-14

Agarwal P, Kumar S, Hariharan S, Eshkar N, Verro P, Cohen B, Sen S.  Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis. 2004:17;182-190.

Barber P, Demchuk A, Zhang J, Kasner S, Hill M, Berrouschot J, Schmutzhard E, Harms L, Verro P, Krieger D.  Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis. 2003;16:230-235

Barber P, Demchuck A, Zhang J, Kasner S, Berrouschot J, Schmutzhard E, Harms L, Verro P, Krieger D.  Multicenter Experience of large middle cerebral artery infarction: the role of repeat CT for predicting fatal outcome.  Cerebrovasc Dis. 2003;16(3):230-5

Verro, P, Tanenbaum L, Borden N, Sen S, Eshkar N.  CT angiography in acute ischemic stroke: preliminary results.  Stroke 2002; 33:276-8.

Kasner S, Demchuk A, Berrouschot J, Schmutzhard E, Harms L, Verro P, Chalela J, Abbur R, McGrade H, Christou K, Krieger D.  Predictors of fatal brain edema in massive hemispheric ischemic stroke.  Stroke 2001; 32:2117-2123.

Albers, G., Bates, V., Clark, W., Bell, R., Verro, P., Hamilton, S.: Prospective, Monitored,  Multicenter, Post-Approval Experience with Intravenous t-PA for Treatment of Acute Stroke: The Standard Treatment with Activase to Reverse Stroke (STARS).  JAMA  2000;283: 1145-1150

Tanne, D., Gorman, M., Bates, V., Kasner, S., Verro, P., et al: Intravenous t-PA for Acute Ischemic Stroke in Patients Age 80 and over: the t-PA Stroke Survey Experience.  Stroke , 2000; 31:370-375.

Tanne, D., Bates, V., Verro, P., et al: Initial Clinical Experience with IV t-PA for Acute Ischemic Stroke: a Multicenter Survey.  Neurology, 1999; 53: 424-427

Verro, P; Levine, S.; Tietjen, G. Cerebrovascular ischemic events with high positive
  Anticardiolipin Antibodies. Stroke - 1998; 29:2245-2253

Verro, P; Levine, R.; Turski, P.; Pardington, C.  Clinical Utility of Magnetic Resonance Angiography in Evaluation of Vertebrobasilar Insufficiency:  Initial Experience. Journal of Neuro-imaging, 3:132-138, 1993.

Levine, R, Verro, P., et al: Magnetic Resonance Angiographic Study of Vertebral-Basilar Flow Voids.  Journal of Neuroimaging, 2: 175-180, 1992